Conversa Health Closes $20M Series B
PORTLAND, OR, Conversa Health, a leading virtual care and triage platform, has expanded its Series B financing to $20 million.
Conversa Health has expanded its Series B financing to $20 million during a year in which the company experienced sixfold growth of its platform. With the closing of the Series B round, Conversa has raised a total of $34 million. The Series B round, first announced at $12 million in June, was co-led by Builders VC and Northwell Ventures, the corporate venture arm of Northwell Health, New York's largest healthcare provider with 23 hospitals and 800 outpatient facilities.
In addition to co-leads Builders VC and Northwell Ventures, the investor syndicate includes UH Ventures, the venture arm of University Hospitals, an 18-hospital health system in Ohio; and venture capital firms P5 Health Ventures, Genesis Merchant Capital, J-Ventures, Epic Ventures, StartUp Health and Nassau Street Ventures.
Conversa is a leader in automated virtual health at scale. Conversa's Automated Virtual Care and Triage platform utilizes its proprietary patient profiling and health signals engine and an extensive library of evidence-based digital pathways to help healthcare organizations effectively and efficiently risk stratify and remotely manage patients across the care continuum. Leading health systems, payers, employers and pharmaceutical companies are using Conversa to develop meaningful relationships and drive better health outcomes. To learn more, visit conversahealth.com, follow @ConversaHealth or text HELLO to 77877.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
(c) by Massinvestor, Inc. For contact info, please check out our about